abstract |
The present invention provides compounds that modulate histone acyltransferase (HAT) and compositions comprising the same. The present invention further provides for use in the treatment of neurodegenerative disorders associated with accumulated amyloid-beta peptide deposits, tau protein levels, and/or accumulation of alpha-synuclein by administering to a subject a compound that modulates HAT symptoms and methods of cancer. |